Montis Cellular Therapy
The Most Advanced Regenerative Medicine Platform Available. Backed by Over 100 Years of German Cellular Research.
The Science Behind It
Montis Cellular Therapy is developed under the research framework of DFGTT (Deutsch-Französische Gesellschaft für Thymus Therapie) — backed by over 100 years of German cellular therapy research tradition. The source material is pathogen-free fetal sheep cells (SPF certified), processed through advanced lyophilization (freeze-drying) technology to preserve full biological activity.
The Three Tiers — How It's Delivered
Mega+: The most comprehensive tier. Contains full cell factors, proteins, peptides, and amino acids. Single high-impact administration for immediate systemic regenerative activation.
Macro: Contains up to 750 proteins. Administered twice weekly over 10 weeks for chronic disease management and deep structural restoration.
Micro: Contains up to 10 targeted peptides. Used weekly over 6 to 12 sessions for preventive maintenance and longevity optimisation.
Programme 1 — General Revitalisation
Goal: A complete systemic biological reset — restoring vitality, rebalancing hormones, strengthening immunity, and slowing biological ageing across every major organ system simultaneously.
Targets: Heart · Liver · Cerebrum · Adrenal Gland · Spleen · Thymus · Placenta · Ovary/Testis · Kidney · Ectoderm Stem Cell · Mesenchymal Stem Cell · Endoderm Stem Cell
Best for: Anyone experiencing early functional decline · Active agers 55+ · High-performance executives or athletes · Burnout or chronic stress at any age
Expected outcomes: Increased energy and stamina · Sharper cognitive clarity · Enhanced stress tolerance · Stronger immune resilience · Hormonal stabilisation
Programme 2 — Brain Health
Goal: A precision multi-region neurological regeneration protocol targeting the entire central nervous system — from cortex to spinal cord.
Targets: Cerebrum · Frontal Lobe · Hypothalamus · Cerebral Cortex · Pineal Gland · Mesencephalon · Cerebellum · Medulla Oblongata · Spinal Cord · Ectoderm Stem Cell
Best for: Brain fog, memory lapses (age 40+) · Neurodegenerative risk · Chronic stress and burnout · Post-stroke recovery · High-performance clients seeking cognitive edge
Expected outcomes: Improved memory and learning · Sharper focus · Better sleep quality · Reduced brain fog · Improved motor coordination · Greater emotional resilience
Programme 3 — Cancer Prevention
Goal: A proactive biological defence protocol — rebuilding the immune organs, detoxification systems, and cellular environments that collectively determine whether your body can detect, suppress, and eliminate abnormal cells. This is NOT a cancer treatment.
Targets: Thymus · Liver · Gut · Spleen · Mesenchymal Stem Cell · Endoderm Stem Cell
Best for: Family history of cancer · Post-cancer remission · Chronic inflammation · High toxic burden profiles · Gut and liver dysfunction
Expected outcomes: Restored T-cell diversity · Enhanced NK cell activity · Reduced chronic inflammatory markers · Improved liver detoxification
Programme 4 — Immune Enhancer
Goal: A complete biological reconstruction of every system that produces, regulates, and deploys immune function simultaneously.
Targets: Cerebrum · Pineal Gland · Heart · Adrenal Gland · Thymus · Gut · Liver · Placenta · Mesenchymal Stem Cell · Endoderm Stem Cell
Best for: Frequent illness, slow recovery · Age-related immune decline (45+) · Post-illness recovery · Chronic stress and burnout · High-performance individuals
Expected outcomes: Enhanced NK cell and T-cell activity · Stronger first-line mucosal defence · Faster pathogen recognition · Reduced frequency and severity of infections
Programme 5 — Metabolic Health
Goal: A comprehensive multi-organ metabolic regeneration protocol addressing every node of the metabolic disease network simultaneously.
Targets: Cerebrum · Heart · Artery · Liver · Gut · Pancreas · Kidney · Placenta · Mesenchymal Stem Cell · Endoderm Stem Cell
Best for: Type 2 diabetes or pre-diabetes · Metabolic syndrome · Non-alcoholic fatty liver disease (NAFLD) · Cardiovascular metabolic risk · Chronic fatigue from mitochondrial inefficiency
Expected outcomes: Improved fasting glucose and HbA1c · Better lipid profile · Improved blood pressure · Reduced visceral fat · More stable energy
Programme 6 — Osteo Health (Bone & Joint)
Goal: A precision multi-target musculoskeletal regeneration protocol addressing every biological layer of bone and joint health.
Targets: Bone Marrow · Osteoblast · Cartilage · Synoviocytes · Muscle · Ovary/Testis · Artery · Mesenchymal Stem Cell (double dose)
Best for: Osteoporosis or osteopenia · Osteoarthritis · Post-menopausal women with rapid bone density decline · Men over 45 with testosterone-related bone and muscle loss · Post-fracture recovery · Sarcopenia
Expected outcomes: Reduced joint pain and stiffness · Improved range of motion · Improved bone density markers (DEXA at 6 and 12 months)
Programme 7 — Skin Firmer
Goal: A precision multi-layer biological skin rejuvenation protocol — rebuilding the skin from within, across every biological layer simultaneously. Topical products address the surface. This protocol addresses the biology beneath it.
Targets: Cutis (Skin) · Ovary/Testis · Muscle · Placenta · Mesenchymal Stem Cell · Endoderm Stem Cell
Best for: First signs of skin ageing, firmness loss, fine lines (age 30-45) · Peri- and post-menopausal women with rapid collagen loss · Post-weight loss skin laxity
Expected outcomes: Visibly improved skin firmness and tissue density · Reduced fine line and wrinkle depth · Restored facial contour and structural lift · Smoother, more luminous skin tone
Intravenous allogeneic mesenchymal stem cell therapy was safe in individuals with ageing frailty. Treated groups showed remarkable improvements in physical performance and inflammatory biomarkers. The 6-minute walk test, short physical performance exam, and lung function all improved significantly (p = 0.01). Serum TNF-a inflammatory markers decreased significantly (p = 0.03).
Second study — Stem Cell Research and Therapy (Springer Nature), 2024: MSC transplantation demonstrated significant improvements in grip strength (p = 0.002) and physical performance. Inflammatory cytokines TNF-a and IL-17 showed significant declines at 6 months.
Frequently Asked Questions
Begin Your Regenerative Journey
The most advanced regenerative medicine available. Grounded in over a century of German cellular research. Delivered in the most prepared biological environment possible. Book your consultation with the Montis team today.
Book Your Consultation →